Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Fuchsjager, M; Shukla-Dave, A; Akin, O; Barentsz, J; Hricak, H.
Prostate cancer imaging
Acta Radiol. 2008; 49(1):107-120
Doi: 10.1080/02841850701545821
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Fuchsjäger Michael
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- As prostate cancer is a biologically heterogeneous disease for which a variety of treatment options are available, the major objective of prostate cancer imaging is to achieve more precise disease characterization. Magnetic resonance imaging (MRI) may enhance the staging of prostate cancer compared with clinical evaluation, transrectal ultrasound, or computed tomography (CT), and allows concurrent evaluation of prostatic, periprostatic, and pelvic anatomy. In clinical practice, the fusion of MRI or dynamic contrast-enhanced MRI (DCE-MRI) with MR spectroscopic imaging (MRSI) is improving the evaluation of cancer location, size, and extent, while providing an indication of tumor aggressiveness. Pretreatment knowledge of these prognostic variables is essential for achieving minimally invasive, patient-specific therapy.
- Find related publications in this database (using NLM MeSH Indexing)
- Diffusion Magnetic Resonance Imaging - methods
- Humans -
- Magnetic Resonance Imaging - methods Magnetic Resonance Imaging - trends
- Magnetic Resonance Spectroscopy - methods
- Male -
- Neoplasm Staging -
- Positron-Emission Tomography - methods
- Prostate - pathology Prostate - radiography Prostate - radionuclide imaging
- Prostatic Neoplasms - diagnosis
- Tomography, X-Ray Computed - methods
- Find related publications in this database (Keywords)
- CT
- MR diffusion/perfusion
- MR imaging
- MR spectroscopy
- neoplasms
- primary
- prostate